EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine Learning‐Informed Nano Co‐Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue

Zehua Liu, Qiang Long, Yihao Liu, Xiuqiao Sun, Baoding Zhang, Binxin Liao, Weibin Wu, Wangxi Hai, Pei Zhang, Wenhua Lian, Yuewen Zhu, Zheng Wang und 4 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.202519805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Zehua Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Machine Learning, Gelatinases, Membrane Proteins, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation for Distinguished Young Scholars of China, Academy of Finland, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticle‐based drug delivery faces persistent challenges, including complex fabrication processes and limited lesional accumulation. Here we introduce SP‐13786 (SP), a precise small‐molecule inhibitor of fibroblast activation protein (FAP), as a universal and effective excipient enabling facile co‐precipitation into stable nanoparticles (SCAN) with diverse hydrophobic drugs. Screening of 861 compounds revealed a broadly enhanced colloidal stability and drug loading by SP. Corresponding simulations and explainable machine learning (XML) showed SCAN assembly hinges on balanced aromaticity, rigidity, and nitrogen‐mediated interaction, offering interpretable framework for co‐assembly nanomedicine. Biological assessment demonstrate that SCAN enhances drug delivery and therapeutic efficacy in FAP‐positive cells, therefore attentuate the fibrosis‐induced drug penetration barriers, increasing drug accumulation within the fibrotic tissue. The improved bioavailability correlate with superior therapeutic outcomes in multiple disease models with progressive fibrosis. Overall, we establish SP as a versatile nanotherapeutic platform combining simplicity in preparation, mechanistic insights provided by XML, and broad applicability for diseases characterized by pathological fibrosis and impaired drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningGelatinasesMembrane ProteinsNanoparticlesDrug CarriersDrug Delivery SystemsFibroblast Activation Protein AlphaFibrosisAnimalsEndopeptidasesHumansSerine EndopeptidasesMice

Stichwörter der Autor:innen

fibroblast activation proteinmyocardial reperfusion injurypancreatic tumorquantitative structure‐property analysisresponsive drug deliveryself‐assembly nanoparticles

Substanzen

Fibroblast Activation Protein AlphaGelatinasesMembrane ProteinsEndopeptidasesSerine EndopeptidasesDrug Carriers

Autor:innen und Institutionen

  • Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Department of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.
  • Department of Cardiovascular Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
  • School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.

ORCID-Profile: Xianming Deng, Hélder A Santos, Xiaofeng Ye

Förderung

  • National Natural Science Foundation for Distinguished Young Scholars of China
  • Academy of Finland
  • Natural Science Foundation of China
  • Shanghai Sailing Program
  • China Postdoctoral Science Foundation
  • National Key Research and Development Program of China
  • UMCG Research Funds
  • Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China

Zitieren

APA

Liu, Z., Long, Q., Liu, Y., Sun, X., Zhang, B., Liao, B., Wu, W., Hai, W., Zhang, P., Lian, W., Zhu, Y., Wang, Z., Wu, C., Deng, X., Santos, H. A., & Ye, X. (2026). Machine Learning‐Informed Nano Co‐Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue. Advanced Materials. https://doi.org/10.1002/adma.202519805

Vancouver

Liu Z, Long Q, Liu Y, Sun X, Zhang B, Liao B, et al. Machine Learning‐Informed Nano Co‐Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue. Advanced Materials. 2026. doi:10.1002/adma.202519805

BibTeX
@article{Liu2026,
  author = {Liu, Zehua and Long, Qiang and Liu, Yihao and Sun, Xiuqiao and Zhang, Baoding and Liao, Binxin and Wu, Weibin and Hai, Wangxi and Zhang, Pei and Lian, Wenhua and Zhu, Yuewen and Wang, Zheng and Wu, Caisheng and Deng, Xianming and Santos, Hélder A and Ye, Xiaofeng},
  title = {Machine Learning‐Informed Nano Co‐Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202519805}
}
Kostenlos starten →